Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription 13.07.2026 1 Am Heart J 1 Am J Epidemiol 1 Am J Ophthalmol 1 BMJ 1 Circulation 1 Clin Chem 4 Diabet Med 1 Diabetes 8 Diabetes Care 24 Diabetes Obes Metab 2 Invest Ophthalmol Vis Sci 2 J Diabetes Complications 1 J Exp Med 1 J Nutr 1 PLoS Med 5 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. VILLASCHI A, Pini D, Stolfo D, Baldetti L, et al
   Cardio-kidney-metabolic overlap in patients with severe heart failure: data from the HELP-HF registry.
   Am Heart J. 2026 Jun 3:107508. doi: 10.1016/j.ahj.2026.107508.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

2. MONTGOMERY BW, Elkasabi M, Brannock MD, Marcial L, et al
   Assessing the generalizability of prevalence estimates from the All of Us Research Program.
   Am J Epidemiol. 2026;195:1962-1973.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

3. TRAN J, Chhablani J
   Unsuccessful Clinical Trials in Retina: Lessons Learned.
   Am J Ophthalmol. 2026;288:284-294.
   PubMed         Abstract available
   
   

   
   BMJ

4. EVANS L
   Life with type 1 diabetes is much more than numbers.
   BMJ. 2026;394:e278125.
   PubMed        
   
   

   
   Circulation

5. PIGEYRE M, Gerstein HC
   Cardiovascular Risk Reduction With GLP-1 RA Drugs.
   Circulation. 2026;154:66-73.
   PubMed         Abstract available
   
   

   
   Clin Chem

6. MORADIAN A, Becker JO, Nierves LA, Lin TT, et al
   Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.
   Clin Chem. 2026 Jul 4:hvag078. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Diabet Med

7. WAITE MA, Kozlowska O, Martin C, Krezalek M, et al
   Piloting an immersive virtual reality 3D self-management education experience for adults with type 1 and type 2 diabetes mellitus: A qualitative study.
   Diabet Med. 2026 Jul 8:e70383. doi: 10.1111/dme.70383.
   PubMed         Abstract available
   
   
8. JONES PJ, Najafi B, Davies MJ, Sarkar P, et al
   Effect of recommended footwear fit upon in-shoe pressures in feet with diabetes-An exploratory study.
   Diabet Med. 2026 Jul 7:e70418. doi: 10.1111/dme.70418.
   PubMed         Abstract available
   
   
9. LEAN M, Davies A
   Re: Interpreting the cost-effectiveness of diabetes remission programmes beyond the durability of remission.
   Diabet Med. 2026 Jul 7:e70410. doi: 10.1111/dme.70410.
   PubMed        
   
   
10. SKUDAR S
    Interpreting the cost-effectiveness of diabetes remission programmes beyond the durability of remission.
    Diabet Med. 2026 Jul 7:e70393. doi: 10.1111/dme.70393.
    PubMed        
    
    

    
    Diabetes

11. PRASAD AV, Mathai TS, Balamuralikrishna PTS, Batheja V, et al
    Utility of Pancreatic Perivascular Adipose Tissue as a CT Imaging Biomarker for Diagnosing Type 2 Diabetes.
    Diabetes. 2026 Jul 9:db251140. doi: 10.2337/db25-1140.
    PubMed         Abstract available
    
    

    
    Diabetes Care

12. VALGAERTS L, De Meulemeester J, Visser MM, Charleer S, et al
    The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Technology: A One-Year Analysis.
    Diabetes Care. 2026 Jul 6:dc260763. doi: 10.2337/dc26-0763.
    PubMed         Abstract available
    
    
13. PYATAK EA, Schneider S, Hernandez R, Hoogendoorn C, et al
    Habituation to Elevated Glucose Levels in Type 1 Diabetes: Function and Well-Being in Guideline-Based Versus Typical Glycemic Range.
    Diabetes Care. 2026 Jul 7:dc260603. doi: 10.2337/dc26-0603.
    PubMed         Abstract available
    
    
14. KHANDAN A, Dehghan Rouzi M, Armstrong DG, Najafi B, et al
    Predicting the Path to Attrition: Multidomain Risk Assessment in Diabetic Foot Ulcer Offloading Randomized Controlled Trials.
    Diabetes Care. 2026 Jul 7:dc260658. doi: 10.2337/dc26-0658.
    PubMed         Abstract available
    
    
15. THELIN MA, Cho S, Callebaut A, Nguyen H, et al
    Type 1 Diabetes Driven by Residual Recipient T Cells After Hematopoietic Cell Transplantation: A Case Report.
    Diabetes Care. 2026 Jul 7:dc260795. doi: 10.2337/dc26-0795.
    PubMed         Abstract available
    
    
16. DREVES B, Joubert M
    Reactive Hypoglycemia as a Transient Metabolic Phenotype of Stage 1 and 2 Type 1 Diabetes.
    Diabetes Care. 2026 Jul 8:dc260921. doi: 10.2337/dc26-0921.
    PubMed        
    
    
17. CALLIGARO LI, Liew G, Cho YH, Allen DW, et al
    30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes.
    Diabetes Care. 2026 Jul 8:dc260388. doi: 10.2337/dc26-0388.
    PubMed         Abstract available
    
    
18. ABUABAT MI, Budhram D, Bapat P, Bakhsh A, et al
    Detectable C-Peptide and Diabetic Ketoacidosis Risk in Type 1 Diabetes.
    Diabetes Care. 2026 Jul 9:dc260220. doi: 10.2337/dc26-0220.
    PubMed         Abstract available
    
    
19. GOODMAN IR, Berry SA, McNally EH, Martine-Edith G, et al
    Effects of the Omnipod 5 Hybrid Closed-Loop System in People With Type 1 Diabetes With Impaired Awareness of Hypoglycemia.
    Diabetes Care. 2026 Jul 10:dc260422. doi: 10.2337/dc26-0422.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

20. ALKABBANI W, Crisafulli S, Paik JM, Tavakkoli A, et al
    Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study.
    Diabetes Obes Metab. 2026;28:7494-7504.
    PubMed         Abstract available
    
    
21. BICKELMANN C, Wilden C, Prates-Roma L, Laschke MW, et al
    Inflammatory Cytokines Impair Glucagon Expression and Secretion in Pancreatic alpha-Cells.
    Diabetes Obes Metab. 2026;28:7149-7160.
    PubMed         Abstract available
    
    
22. HOLLINGHURST J, Augusto M, Tefos F, Bauer R, et al
    Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction-Associated Steatohepatitis.
    Diabetes Obes Metab. 2026;28:7058-7072.
    PubMed         Abstract available
    
    
23. YOKOTE K, Yamauchi T, Fukushima Y, Takatsuka Y, et al
    Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE-JP Trial.
    Diabetes Obes Metab. 2026;28:6595-6606.
    PubMed         Abstract available
    
    
24. DE FANO M, Haurum LL, Schwarz CR, Porcellati F, et al
    GIP in Cardiovascular and Kidney Disease: From Physiology to Pharmacology.
    Diabetes Obes Metab. 2026;28:6509-6532.
    PubMed         Abstract available
    
    
25. TALAY L, Hom J, Tan M, Ahuja N, et al
    Real-World Effectiveness and 12-Month Persistence of a Semaglutide-Supported Digital Weight-Loss Service: A Retrospective Cohort Study in Germany.
    Diabetes Obes Metab. 2026;28:6985-6996.
    PubMed         Abstract available
    
    
26. COELHO AI, Vale C, Leite AR, Borges-Canha M, et al
    The Potential Role of SGLT2 Inhibitors in Cushing's Disease.
    Diabetes Obes Metab. 2026;28:6550-6560.
    PubMed         Abstract available
    
    
27. HSIEH WC, Henry BM, Edes I
    The Effects of Combined Antihypertensive and Antidiabetic Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
    Diabetes Obes Metab. 2026;28:6874-6887.
    PubMed         Abstract available
    
    
28. HUSSAIN T, Al Faysal J, Kotecha P, Ramon R, et al
    Association of GLP-1 Receptor Agonist Use With Safety Outcomes in Individuals With Opioid Use Disorder: A Target Trial Emulation.
    Diabetes Obes Metab. 2026;28:6861-6873.
    PubMed         Abstract available
    
    
29. CHAN TH, Cosler LE, Gionfriddo MR, Leppien EE, et al
    Association Between Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: A Systematic Review.
    Diabetes Obes Metab. 2026;28:6482-6508.
    PubMed         Abstract available
    
    
30. SU S, Zhou S, Zhou T, Li J, et al
    Long-Term Glycemic Exposure, Control Status and Cognitive Function in Older Adults: A Longitudinal Study.
    Diabetes Obes Metab. 2026;28:6744-6754.
    PubMed         Abstract available
    
    
31. KIM YJ, Cho YK, Kim MS, Lee J, et al
    Association Between SGLT2 Inhibitors and DPP-4 Inhibitors Use and Risk of Acute Pancreatitis: Findings From Nationwide Case-Based Analyses.
    Diabetes Obes Metab. 2026;28:6767-6775.
    PubMed         Abstract available
    
    
32. SILVA CFXCA, de Souza BL, Thomazini G, Junior J, et al
    GLP-1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta-Analysis.
    Diabetes Obes Metab. 2026;28:6735-6743.
    PubMed         Abstract available
    
    
33. KAZE AD, Juraschek SP, Cohen JB, Singh S, et al
    Prediabetes, Malignant Ventricular Hypertrophy and Stroke: The SPRINT Trial.
    Diabetes Obes Metab. 2026;28:6725-6734.
    PubMed         Abstract available
    
    
34. HEISEY HD, Gregg LP, Verrico CD, Villareal DT, et al
    Rates of, Reasons for, and Reactions to Discontinuation of GLP-1 Receptor Agonists: A Narrative Review.
    Diabetes Obes Metab. 2026;28:6533-6549.
    PubMed         Abstract available
    
    
35. KAKKAR AK, Payra S, Charaya A
    Optic Ischaemic Neuropathy in Incretin-Based Therapy: A Comparative Analysis of Real-World Safety Data.
    Diabetes Obes Metab. 2026;28:7527-7535.
    PubMed         Abstract available
    
    
36. KOSTEV K, Sievert H, Konrad M, Sarabhai T, et al
    Epidemiological Studies on Type 2 Diabetes Using the German Disease Analyser Database: A Narrative Review.
    Diabetes Obes Metab. 2026 Jul 6. doi: 10.1111/dom.71089.
    PubMed         Abstract available
    
    
37. BERRY SA, Goodman IR, McNally E, Elliott J, et al
    Real-World Effectiveness and Safety of Tirzepatide in Type 1 Diabetes and Obesity: Impact on Glycaemia, Weight, and Cardiometabolic Risk Markers.
    Diabetes Obes Metab. 2026 Jul 6. doi: 10.1111/dom.71080.
    PubMed         Abstract available
    
    
38. LEI M, Lin Q, Zhou Y, Ni Y, et al
    Efficacy and Safety of Tubeless Hybrid Closed-Loop Systems in Type 1 Diabetes: A Meta-Analysis of Randomized Controlled Trials.
    Diabetes Obes Metab. 2026 Jul 6. doi: 10.1111/dom.71061.
    PubMed         Abstract available
    
    
39. KAMRUL-HASAN ABM, Chatterjee S, Ashraf H, Nagendra L, et al
    Efficacy and Safety of the Dual Glucagon-Like Peptide-1 and Glucagon Receptor Agonist Mazdutide in Predominantly Chinese Adults With Obesity and/or Type 2 Diabetes: A Systematic Review and Meta-Analysis.
    Diabetes Obes Metab. 2026 Jul 6. doi: 10.1111/dom.71058.
    PubMed         Abstract available
    
    
40. LI D, Ouyang L, Chen Z, Long Y, et al
    Efficacy and Safety of Ion Channel Modulators in Painful Diabetic Neuropathy.
    Diabetes Obes Metab. 2026 Jul 8. doi: 10.1111/dom.71053.
    PubMed         Abstract available
    
    
41. CHEN RT, Nelson AJ, Zoungas S, Clark RA, et al
    Baseline Computed Tomography Coronary Angiography and Polygenic Risk Profiles in Adults With Type 2 Diabetes: A Cross-Sectional Analysis From the VOLTAIRE Study.
    Diabetes Obes Metab. 2026 Jul 8. doi: 10.1111/dom.71072.
    PubMed         Abstract available
    
    
42. ANSON M, Iqbal A, Azmi S, Weston P, et al
    Early Worsening of Diabetic Retinopathy Following Initiation of Hybrid Closed-Loop/Automated Insulin Delivery Systems in Type 1 Diabetes: A Systematic Review and Structured Study-Level Synthesis.
    Diabetes Obes Metab. 2026 Jul 8. doi: 10.1111/dom.71084.
    PubMed         Abstract available
    
    
43. OLIVER N, Gehr B, Lal R, van Dijk PR, et al
    Continuous Intraperitoneal Insulin Infusion for People With Type 1 Diabetes: A Literature Review and International Position Statement.
    Diabetes Obes Metab. 2026 Jul 9. doi: 10.1111/dom.71054.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

44. ZONG Y, Fan Q, Qiu S, Zhang H, et al
    The Molecular Basis of Ocular Aging: Mechanisms, Pathologies, and Emerging Therapeutics.
    Invest Ophthalmol Vis Sci. 2026;67:13.
    PubMed         Abstract available
    
    
45. LI N, Liu L, Sun W, Liu D, et al
    Whole-Exome Analysis Identifies Candidate Genes Associated With Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:25.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

46. EDENS MA, Rosien L, van Dijk PR, Bilo H, et al
    Survival and healthcare reimbursements of individuals with lower extremity amputation performed in hospitals with and without a multidisciplinary diabetic foot team: A nationwide study using Dutch reimbursement data (DUDE 12).
    J Diabetes Complications. 2026;40:109363.
    PubMed         Abstract available
    
    
47. SONMEZ A, Haymana C, Demirci I, Cetinarslan B, et al
    Turkish cross-sectional survEy of glycemic and other Metabolic parameters in patients with type 2 Diabetes in 2023: Comparison with 2018 nationwide data (TEMD-2 study).
    J Diabetes Complications. 2026;40:109348.
    PubMed         Abstract available
    
    

    
    J Exp Med

48. NABI R, Lin CW, Wang Y, Ciecko AE, et al
    Both soluble and cell surface CD137 expressed by Foxp3+ CD4 T cells restrain autoimmune diabetes.
    J Exp Med. 2026;223:e20252647.
    PubMed         Abstract available
    
    

    
    J Nutr

49. CLISTER D, Chandra QM, Tan MW, Gunawan MC, et al
    Microbiome-Based Precision Interventions in Type 2 Diabetes Mellitus: Mechanisms, Modulators, and Translational Opportunities.
    J Nutr. 2026;156:101596.
    PubMed         Abstract available
    
    

    
    PLoS Med

50. MANYARA AM, Abdullah S, Balshaf A, Manyanga T, et al
    Hypertension and diabetes prevalence, associated factors, care cascade, and quality of life in older adults: A cross-sectional population-based study in The Gambia, South Africa, and Zimbabwe.
    PLoS Med. 2026;23:e1004785.
    PubMed         Abstract available
    
    

    
    PLoS One

51. SONG L, Zhou L, Li W
    Molecular mechanisms of autophagy disorder in diabetic neuropathy: Focusing on signaling pathways and regulation of lipid metabolism.
    PLoS One. 2026;21:e0344082.
    PubMed         Abstract available
    
    
52. KIM S, Sang H, Park J, Woo S, et al
    Machine learning for predicting emergency department visits in patients with type 2 diabetes: A real-world, multi-institutional study.
    PLoS One. 2026;21:e0352342.
    PubMed         Abstract available
    
    
53. KUSUMAWATI N, Pijl H, Alaofe H, Yani E, et al
    Knowledge, attitudes, and practices regarding type 2 diabetes and associated factors among rural adolescents in Indonesia: A cross-sectional study.
    PLoS One. 2026;21:e0352982.
    PubMed         Abstract available
    
    
54. CROMER SJ, Gervis JE, Burnett-Bowie SM, Patel CJ, et al
    Heterogeneous associations of socioeconomic status with metabolic disease in racial and ethnic subgroups in the United States: A cross-sectional cohort study in NHANES and All Of Us.
    PLoS One. 2026;21:e0351075.
    PubMed         Abstract available
    
    
55. ZHU G, Zou K, Liang Y, Xie L, et al
    Discovery of hub genes linking oxidative stress to type 2 diabetic sarcopenia using single-cell sequencing and machine learning.
    PLoS One. 2026;21:e0352753.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum